Neuroton (Citicoline Sodium)

Citicoline Sodium, the active ingredient in Neuroton, is a cholinergic agent presented as an injectable solution for intramuscular and intravenous use. It is employed to support patients with ischemic stroke, traumatic brain injury, and cognitive impairment.

GNH USA supplies Neuroton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from comprehensive regulatory support, temperature‑controlled shipping where required, and dedicated technical assistance throughout the procurement process.

Neuroton, a cholinergic nootropic, acts on neuronal membrane integrity and neurotransmitter synthesis in various neurological conditions. - Ischemic stroke: improves functional recovery by supporting neuronal membrane repair and enhancing acetylcholine production. - Traumatic brain injury: aids in neuroprotection and cognitive restoration following head trauma. - Cognitive impairment: enhances attention and memory performance in patients with mild to moderate deficits.

Adverse reactions to Neuroton are generally mild, but clinicians should be aware of both common and serious potential effects.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal upset. - Insomnia: difficulty initiating sleep. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Allergic reaction: rash, pruritus, or angioedema. - Hypotension: marked blood pressure drop. - Seizure: rare convulsive episodes. - Hepatic enzyme elevation: abnormal liver function tests.

Prior to initiating Neuroton therapy, consider the following precautions to ensure safe use. - Renal impairment: monitor renal function and adjust therapy as needed. - Pregnancy: safety not established; avoid unless potential benefit outweighs risk. - Breastfeeding: unknown excretion; consider discontinuation. - Concomitant anticoagulants: observe for increased bleeding tendency. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Neuroton may interact with other medicines; awareness of significant interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: risk of hypertensive crisis; avoid co‑administration. - Anticholinergic drugs: may diminish Neuroton’s efficacy; avoid concurrent use. - Warfarin: potential increase in bleeding risk; avoid combination.

Moderate Interactions (Monitor Closely): - Caffeine: may enhance central nervous system stimulation; monitor for agitation. - Other cholinergic agents: additive cholinergic effects; adjust dosage if needed. - Diuretics: possible electrolyte disturbances; observe laboratory values.